Levy O, Ooi C E, Weiss J, Lehrer R I, Elsbach P
Department of Microbiology, New York University School of Medicine, New York 10016.
J Clin Invest. 1994 Aug;94(2):672-82. doi: 10.1172/JCI117384.
Affinity purification of crude acid extracts of rabbit polymorphonuclear leukocytes using Escherichia coli (J5) as adsorbent yields the bactericidal/permeability-increasing protein (BPI), two 15-kD species (p15s), and the two most potent (cationic) defensin species (neutrophil peptides [NP] -1 and -2). Tested in buffered isotonic medium, the relative antibacterial potency of these proteins against E. coli J5 is BPI (IC50 0.2 nM) > p15A (10 nM) > NP -1 (400 nM). Sublethal doses of p15A or NP-1 can synergize with BPI to decrease the dose required to inhibit the growth of E. coli by up to 50-fold. BPI and p15A display similar features of antibacterial action distinct from defensin NP-1, but NP-1 acts synergistically only with BPI and not with p15A. All aspects of the combined action of BPI and NP-1 resemble those observed with higher concentrations of BPI alone, implying that NP-1 enhances BPI potency. Neither NP-1 nor p15A alter the amount of BPI binding to E. coli but BPI enhances binding of p15A to E. coli, raising the possibility that synergy between these two proteins may occur at least partially at the level of binding. The potent synergistic actions of these proteins can also be demonstrated against serum-resistant clinical isolates of encapsulated E. coli tested in whole blood and plasma ex vivo, suggesting that such combined action may contribute to host defense in vivo.
以大肠杆菌(J5)为吸附剂,对兔多形核白细胞的粗酸提取物进行亲和纯化,可得到杀菌/通透性增加蛋白(BPI)、两种15-kD蛋白(p15s)以及两种最有效的(阳离子)防御素(中性粒细胞肽[NP]-1和-2)。在缓冲等渗介质中进行测试,这些蛋白质对大肠杆菌J5的相对抗菌效力为BPI(IC50 0.2 nM)> p15A(10 nM)> NP -1(400 nM)。亚致死剂量的p15A或NP-1可与BPI协同作用,将抑制大肠杆菌生长所需的剂量降低多达50倍。BPI和p15A表现出与防御素NP-1不同的类似抗菌作用特征,但NP-1仅与BPI协同作用,而不与p15A协同作用。BPI和NP-1联合作用的所有方面都类似于单独使用较高浓度BPI时观察到的情况,这意味着NP-1增强了BPI的效力。NP-1和p15A均不改变BPI与大肠杆菌的结合量,但BPI增强了p15A与大肠杆菌的结合,这增加了这两种蛋白质之间的协同作用可能至少部分在结合水平上发生的可能性。这些蛋白质的强效协同作用也可以在全血和血浆中对包膜大肠杆菌的血清抗性临床分离株进行体外测试时得到证明,这表明这种联合作用可能有助于体内的宿主防御。